Microsatellite instability (MSI) as genomic marker in endometrial cancer: Toward scientific evidences

Mini-Reviews in Medicinal Chemistry

Volumn 10, Issue 14, 2010, Pages 1356-1365

  Tinelli, A ^a   Mezzolla, V ^b   Leo, G ^b   Pisano M ^b   Storelli, F ^b   Alemanno, G ^a   Malvasi, A ^c   Tommasi, S ^d   Ronzino, G ^b   Lorusso, V ^b  

^a VITO FAZZI HOSPITAL   (Italy)

^b Oncological Hospital   (Italy)

^c Santa Maria Hospital   (Italy)

^d NATIONAL CANCER INSTITUTE GIOVANNI PAOLO II   (Italy)

Author keywords

Endometrial cancer; Endometrial hyperplasia; Endoscopy; Genomics; Gynecological cancers; HNPCC; Laparoscopy; Lynch sindrome; Malignant uterine cancers; Microsatellite instability; MSI; Proteomics; Uterine tumors

Indexed keywords

NUCLEOTIDE;

ALCOHOL CONSUMPTION; ALLELE; ARTICLE; CHRONIC LIVER DISEASE; COLON CANCER; CULTURAL ANTHROPOLOGY; DIABETES MELLITUS; DIET; DNA MODIFICATION; DNA REPLICATION; ENDOMETRIUM CANCER; EUKARYOTE; GENE INSERTION; GENETIC DISORDER; GENETIC MARKER; GENETIC PREDISPOSITION; GENOMICS; HEREDITARY NONPOLYPOSIS COLORECTAL CANCER; HORMONE SUBSTITUTION; HUMAN; LINKAGE ANALYSIS; MENOPAUSE; MICROSATELLITE INSTABILITY; MISMATCH REPAIR; NONHUMAN; OBESITY; PHENOTYPE; PROKARYOTE;

ANIMALS; ENDOMETRIAL NEOPLASMS; FEMALE; GENETIC LINKAGE; GENOME; HUMANS; MICROSATELLITE INSTABILITY; MUTATION; TUMOR MARKERS, BIOLOGICAL;

EID: 78649806807     PISSN: 13895575     EISSN: None     Source Type: Journal    
DOI: 10.2174/138955710793564098     Document Type: Article

References (49)

1. Tinelli, A.; Vergara, D.; Martignago, R.; Leo, G.; Malvasi, A.; Tinelli, R. Hormonal carcinogenesis and sociobiological development factors in endometrial cancer: a clinical review. Acta. Obstet. Gynecol. Scand., 2008, 18, 1-12.
2. Tinelli, A.; Leo, G.; Vergara, D.; Martignago, R.; Malvasi, A.; Tinelli, R.; Marsigliante, S.; Maffia, M.; Lorusso, V. Endometrial and ovarian cancer: beyond the clinical significance of hormonal carcinogenesis and the promising biomarkers. J. Chin. Clin. Med., 2007, 2(12), 711-720.
3. Tinelli, A.; Leo, G.; Pisanò, M.; Mezzolla, V.; Storelli, F.; Montinari, M.R.; Malvasi, A. Utilization of microsatellite instability (MSI) as genomic markers in endometrial cancer: scientific evidences. Int. J. Gynaecol. Obstet., 2009, 21(1), 49-61.
4. Peltomäki, P.; Vasen, H.F.A. The International Collaborative Group on HNPCC: Mutations predisposing to hereditary nonpolyposis colorectal cancer: Database and results of a collaborative study. Gastroenterology, 1997, 113,1146-1158.
5. Vasen, H.F.; Wijnen, J.T.; Menko, F.H.; Kleibeuker, J.H.; Taal, B.G.; Griffioen, G.; Nagengast, F.M., Meijers-Heijboer, E.H., Bertario, L.; Varesco, L.; Bisgaard, M.L.; Mohr, J.; Fodde, R.; Khan, P.M. Cancer risk in families with hereditary nonpolyposis colorectal cancer diagnosed by mutation analysis. Gastroenterology, 1996, 110(4), 1020-1027.
6. Aarnio, M.; Sankila, R.; Pukkala, E. Cancer risk in mutation carriers of DNA mismatch repair genes. Int. J. Cancer, 1999, 81, 214-218.
7. Kruse, R.; Rutten, A.; Lamberti, C. Muir-Torre phenotype has a frequency of DNA mismatch-repair-gene mutations similar to that in hereditary nonpolyposis colorectal cancer families defined by the Amsterdam criteria. Am. J. Hum. Genet., 1998, 63, 63-70.
8. Vasen, H.F.; Wijnen, J. Clinical implications of genetic testing of hereditary nonpolyposis colorectal cancer. Cytogenet. Cell. Genet., 1999, 86(2), 136-139.
9. Berends, M.J.W.; Wu, Y.; Sijmons, R.H. Molecular and clinical characteristics of MSH6 variants: an analysis of 25 index carriers of a germline variant. Am. J. Hum. Genet., 2002, 70, 26-37.
10. Hamilton, S.R.; Liu, B.; Parsons, R.E.; Papadopoulos, N.; Jen, J.; Powell, S.M.; Krush, A.J.; Berk, T.; Cohen, Z.; Tetu, B. The molecular basis of Turcot's syndrome. N. Engl. J. Med., 1995, 332(13), 839-847.
11. De Rosa, M.; Fasano, C.; Panariello, L. Evidence for a recessive inheritance of Turcot's syndrome caused by compound heterozygous mutations within the PMS2 gene. Oncogene, 2000, 19, 1719-1723.
12. Wu, Y.; Berends, M.J.W.; Sijmons, R.H. A role for MLH3 in hereditary nonpolyposis colorectal cancer. Nat. Genet., 2001, 29, 137-138.
13. Lynch, H.T.; Smyrk, T.C. Overview of natural history, pathology, molecular genetics and management of HNPCC (Lynch Syndrome). Int. J. Cancer, 1996, 69, 38-46.
14. Arabi, H.; Guan, H.; Kumar, S.; Cote, M.; Bandyopadhyay, S.; Bryant, C.; Shah, J.; Abdul-Karim, F.; Munkarah, A.; Ali-Fehmi, R. Impact of microsatellite instability (MSI) on survival in high grade endometrial carcinoma. Gynecol. Oncol., 2009, 113, 153-158.
15. Aaltonen, L.A.; Salovaara, R.; Kristo, P.; Canzian, F.; Hemminki, A.; Peltomäki, P.; Chadzick, R.B.; Kääiriäinen, H.; Eskelinen, M.; Järvinen, H.; Mecklin, J.P.; de la Chapelle, A.; Percesepe, A.; Ahtola, H.; Härkönen, N.; Julkunen, R.; Kangas, E.; Ojala, S.; Tulikoura, J.; Valkamo, E. Incidence of hereditary nonpolyposis colorectal cancer and the feasibility of molecular screening for the disease. N. Engl. J. Med., 1998, 338, 1481-1487.
16. Bennett, P. Microsatellites. Mol. Path., 2000, 53(4), 177-183.
17. Peltomaki, P. DNA mismatch repair gene mutations in human cancer. Environ. Health Perspect., 1997, 105(4), 775-780.
18. Peltomaki, P. DNA mismatch repair and cancer. Mut. Res., 2001, 488(1), 77-85.
19. Cederquist, K.; Emanuelsson, M.; Göransson, I.; Holinski-Feder, E.; Müller-Koch, Y.; Golovleva, I.; Grönberg, H. Mutation analysis of the MLH1, MSH2 and MSH6 genes in patients with double primary cancers of the colorectum and the endometrium: a population- based study in northern Sweden. Int. J. Cancer, 2004, 109 (3), 370-376.
20. Lynch, H.T.; de la Chapelle, A. Hereditary colorectal cancer. N. Engl. J. Med., 2003, 348, 919-932.
21. Kuismanen, S.A.; Holmberg, M.T.; Salovaara, R. Genetic and epigenetic modification of MLH1 accounts for a major share of microsatellite- unstable colorectal cancers. Am. J. Pathol., 2000, 156, 1773-1779.
22. Cunningham, J.M.; Kim, C.Y.; Christensen, E.R. The frequency of hereditary defective mismatch repair in a prospective series of unselected colorectal carcinomas. Am. J. Hum. Genet., 2001, 69, 780-790.
23. Benatti, P.; Gafà, R.; Barana, D.; Marino, M.; Scarselli, A. Microsatellite instability and colorectal cancer prognosis. Clin. Cancer. Res., 2005, 11, 8332-8340.
24. Pinol, V.; Castells, A.; Andreu, M. Accuracy of revised Bethesda guidelines, microsatellite instability and immunohistochemistry for the identification of patients with hereditary nonpolyposis colorectal cancer. JAMA, 2005, 293, 1986-1994.
25. Hampel, H.; Frankel, W.; Panescu, J. Screening for Lynch syndrome (hereditary nonpolyposis colorectal cancer) among endometrial cancer patients. Cancer Res., 2006, 66, 7810-7817.
26. Klug, W.S.; Cummings, M.R. Genetica. Città Studi Ed, Milano, Italy, 2000, pp: 265-281.
27. Klug, W.S.; Cummings, M.R. Genetica. Città Studi Ed, Milano, Italy, 2000, pp: 360-362.
28. Jeffreys, A.J.; Wilson, V.; Thein, S.I. Hypervariable minisatellite regions in human DNA. Nature, 1985, 314, 67-73.
29. Dietmaier, W.; Wallinger, S.; Bocker, T.; Kullmann, F.; Fishel, R.; Rushoff, J. Diagnostic microsatellite instability: definition and correlation with mismatch repair protein expression. Cancer Res., 1997, 57, 4749-4756.
30. Mellersh, C.S.; Ostrander, E.A. The Canine Genome. Adv. Vet. Med. 1997, 40,191-216.
31. Burks, R.T.; Kessis, T.D.; Cho, K.R.; Hedrick, L. Microsatellite instability in endometrial carcinoma. Oncogene, 1994, 9, 1163-1166.
32. Simpkins, S.B.; Bocker, T.; Swisher, E.M. MLH1 promoter methylation and gene silencing is the primary cause of microsatellite instability in sporadic endometrial cancers. Hum. Mol. Genet., 1999, 8, 661-666.
33. Berends, M.J.W.; Wu, Y.; Sijmons, R.H. Molecular and clinical characteristics of MSH6 variants: An analysis of 25 index carriers of a germline variant. Am. J. Hum. Genet., 2002, 70, 26-37.
34. Berends, M.J.; Wu, Y.; Sijmons, R.H. Toward new strategies to select young endometrial cancer patients for mismatch repair gene mutation analysis. J. Clin. Oncol., 2003, 21, 4364-4370.
35. Hampel, H.; Frankel, W.; Panescu, J. Screening for Lynch syndrome (hereditary nonpolyposis colorectal cancer) among endometrial cancer patients. Cancer Res., 2006, 66, 7810-7817.
36. Lu, K.H.; Schorge, J.O.; Rodabaugh, K.J. Prospective determination of prevalence of Lynch syndrome in young women with endometrial cancer. J. Clin. Oncol., 2007, 25, 5158-5164.
37. Duval, A.; Reperant, M.; Compoint, A.; Seruca, R.; Ranzani, G.N.; Iacopetta, B.; Hamelin, R. Target gene mutation profile differs between gastrointestinal and endometrial tumors with mismatch repair deficiency. Cancer Res., 2002, 62, 1609-1612.
38. Myeroff, L.L.; Parsons, R.; Kim, S.J.; Hedrick, L.; Cho, K.R.; Orth, K.; Mathis, M.; Kinzler, K.W.; Lutterbaugh, J.; Park, K.; Bang, Y.J.; Lee, H.Y.; Park, J.G.; Lynch, H.T.; Roberts, A.B.; Vogelstein, B.; Markowitzn, S.D. A transforming growth factor-type II gene mutation common in colon and gastric but rare in endometrial cancers with microsatellite instability. Cancer Res., 1995, 55, 5545-5547.
39. Gurin, C.C.; Federici, M.G.; Kang, L.; Boyd, J. Causes and consequences of microsatellite instability in endometrial carcinoma. Cancer Res., 1999, 59, 462-466.
40. Zhang, L.; Yu, J.; Willson, J.K.V.; Markowitz, S.D.; Kinzler, K.W.; Vogelstein, B. Short mononucleotide repeat sequence variability in mismatch repair-deficient cancers. Cancer Res., 2001, 6, 3801-3805.
41. Samowitz, W.S.; Slattery, M.L.; Potter, J.D.; Leppert, M.F. BAT-26 and BAT-40 instability in colorectal adenomas and carcinomas and germline polymorphisms. Am. J. Pathol., 1999, 154(6), 1637-1641.
42. Futreal, P.A.; Sãderkvist, P.; Marks, J.R.; Iglehart, J.D.; Cochran, C.; Barrett, J.C.; Wiseman, R.W. Detection of frequent allelic loss on proximal chromosome 17q in sporadic breast carcinoma using microsatellite length polymorphisms. Cancer Res., 1992, 52, 2624-2627.
43. Wainszelbaum, M.J.; Charron, A.J.; Kong, C.; Kirkpatrick, D.S.; Srikanth, P.; Barbieri, M.A.; Gygi, S.P.; Stahl, P.D. The hominoidspecific oncogene TBC1D3 activates Ras and modulates epidermal growth factor receptor signaling and trafficking. J. Biol. Chem., 2008, 283(19), 1233-1242.
44. Hodzic, D.; Kong, C.; Wainszelbaum, M.J.; Charron, A.J.; Su, X.; Stahl, P.D. TBC1D3, a hominoid oncoprotein, is encoded by a cluster of paralogues located on chromosome 17q12. Genomics, 2006, 88(6), 731-736.
45. Liu, J.; Albarracin, C.T.; Chang, K.H.; Thompson-Lanza, J.A.; Zheng, W.; Gershenson, D.M.; Broaddus, R.; Luthra, R. Microsatellite instability and expression of hMLH1 and hMSH2 proteins in ovarian endometrioid cancer. Mod. Pathol., 2004, 17, 75-80.
46. Arzimanoglou, I.I.; Lallas, T.; Osborne, M.; Barber, H.; Gilbert, F. Microsatellite instability differences between familial and sporadic ovarian cancers. Carcinogenesis, 1996, 17 (9), 1799-1804.
47. Boland, C.R.; Thibodeau, S.N.; Hamilton, S.R.; Sidransky, D.; Eshleman, J.R.; Burt, R.W.; Meltzer, S.J.; Rodriguez-Bigas, M.A.; Fodde, R.; Ranzani, G.N.; Srivastava, S. A national cancer institute workshop on microsatellite instability for cancer detection and familial predisposition: development of international criteria for the determination of microsatellite instability in colorectal cancer. Cancer Res., 1998, 58, 5248-5257.
48. Shannon, C.; Kirk, J.; Barnetson, R.; Evans, J.; Schnitzler, M.; Quinn, M.; Hacker, N.; Crandon, A.; Harnett, P. Incidence of microsatellite instability in synchronous tumors of the ovary and endometrium. Clin. Cancer Res., 2003, 9, 1387-1392.
49. Shin, J.H.; Kang, S.M.; Kim, Y.S.; Shin, D.H.; Chang, J.; Kim, S.K.; Kim, S.K. Identification of tumor suppressor loci on the long arm of chromosome 5 in pulmonary large cell neuroendocrine carcinoma. Chest, 2005, 128, 2999-3003.